In conclusion, the strudies carried out during the last two decades have clearly shown that CD123 is overexpressed in many hematologic malignancies, including BPDCNs, AMLs, B-ALLs, Hairy Cell Leukemia. This evidence concerns the gene IL3RA and hairy cell leukemia.